AAAAAA
Results:
1-12
|
Results: 12
Authors:
Tanswell, P
Garin-Chesa, P
Rettig, WJ
Welt, S
Divgi, CR
Casper, ES
Finn, RD
Larson, SM
Old, LJ
Scott, AM
Citation: P. Tanswell et al., Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients, BR J CL PH, 51(2), 2001, pp. 177-180
Authors:
Barendswaard, EC
Humm, JL
O'Donoghue, JA
Sgouros, G
Finn, RD
Scott, AM
Larson, SM
Welt, S
Citation: Ec. Barendswaard et al., Relative therapeutic efficacy of I-125- and I-131-labeled monoclonal antibody A33 in a human colon cancer xenograft, J NUCL MED, 42(8), 2001, pp. 1251-1256
Authors:
Lovqvist, A
Humm, JL
Sheikh, A
Finn, RD
Koziorowski, J
Ruan, S
Pentlow, KS
Jungbluth, A
Welt, S
Lee, FT
Brechbiel, MW
Larson, SM
Citation: A. Lovqvist et al., PET imaging of Y-86-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: Comparison between Y-86 and In-111 radiolabels, J NUCL MED, 42(8), 2001, pp. 1281-1287
Authors:
Lee, FT
Hall, C
Rigopoulos, A
Zweit, J
Pathmaraj, K
O'Keefe, GJ
Smyth, FE
Welt, S
Old, LJ
Scott, AM
Citation: Ft. Lee et al., Immune-PET of human colon xenograft-bearing BALB/c nude mice using I-124-CDR-grafted humanized A33 monoclonal antibody, J NUCL MED, 42(5), 2001, pp. 764-769
Authors:
Ritter, G
Cohen, LS
Williams, C
Richards, EC
Old, LJ
Welt, S
Citation: G. Ritter et al., Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33, CANCER RES, 61(18), 2001, pp. 6851-6859
Authors:
Lee, FT
Rigopoulos, A
Hall, C
Clarke, K
Cody, SH
Smyth, FE
Liu, ZQ
Brechbiel, MW
Hanai, N
Nice, EC
Catimel, B
Burgess, AW
Welt, S
Ritter, G
Old, LJ
Scott, AM
Citation: Ft. Lee et al., Specific localization, gamma camera imaging, and intracellular traffickingof radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871in SK-MEL-28 melanoma xenografts, CANCER RES, 61(11), 2001, pp. 4474-4482
Authors:
Ruan, S
O'Donoghue, JA
Larson, SM
Finn, RD
Jungbluth, A
Welt, S
Humm, JL
Citation: S. Ruan et al., Optimizing the sequence of combination therapy with radiolabeled antibodies and fractionated external beam, J NUCL MED, 41(11), 2000, pp. 1905-1912
Authors:
Rader, C
Ritter, G
Nathan, S
Elia, M
Gout, I
Jungbluth, AA
Cohen, LS
Welt, S
Old, LJ
Barbas, CF
Citation: C. Rader et al., The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies, J BIOL CHEM, 275(18), 2000, pp. 13668-13676
Authors:
Deckert, PM
Jungbluth, A
Montalto, N
Clark, MA
Finn, RD
Williams, C
Richards, EC
Panageas, KS
Old, LJ
Welt, S
Citation: Pm. Deckert et al., Pharmacokinetics and microdistribution of polyethylene glycol-modified humanized A33 antibody targeting colon cancer xenografts, INT J CANC, 87(3), 2000, pp. 382-390
Authors:
Sundin, J
Tolmachev, V
Koziorowski, J
Carlsson, J
Lundqvist, H
Welt, S
Larson, S
Sundin, A
Citation: J. Sundin et al., High yield direct Br-76-bromination of monoclonal antibodies using chloramine-T, NUCL MED BI, 26(8), 1999, pp. 923-929
Authors:
Barendswaard, EC
O'Donoghue, JA
Larson, SM
Tschmelitsch, J
Welt, S
Finn, RD
Humm, JL
Citation: Ec. Barendswaard et al., I-131 radioimmunotherapy and fractionated external beam radiotherapy: Comparative effectiveness in a human tumor xenograft, J NUCL MED, 40(10), 1999, pp. 1764-1768
Authors:
Welt, S
Ritter, G
Citation: S. Welt et G. Ritter, Antibodies in the therapy of colon cancer, SEMIN ONCOL, 26(6), 1999, pp. 683-690
Risultati:
1-12
|